9B3-29806-54964
3 vaccinations
6 coded responses
27 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 947 / CA
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 1 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
-
2021-04-17
Dose 2 — Pfizer-BioNTech
- 2021-04-17
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: PainFree text: Lymph node under the injection site arm is painful and swollenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: FairFree text: swollen and sore lymph node in armpit of injected armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-05-17
- 2021-05-22
- 2021-05-29
-
2021-07-17
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend schoolFree text: I have a coldMedDRA releases: 2024-11 · check-in free text available
- 2021-10-16
-
2021-12-12
Dose 3 — Moderna
-
2022-04-17
Survey response — 12 months, dose 2MedDRA: Adverse reaction, Migraine, Photophobia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I don't normally get migraines but my COVID booster triggered about a week and a half of severe migraines with sensitivity to light in addition to the typical symptoms. I've had the occasional migraine since thenMedDRA releases: 2024-11 · check-in free text available
-
2022-06-14
Survey response — 6 months, dose 3MedDRA: Oral candidiasis, Pyrexia, Respiratory symptom, SARS-CoV-2 test positive, Tongue discolouration — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I tested positive for COVID on May 31, 2022 and had fever and moderate respiratory symptoms. It also caused white dots on my tongue which I think is oral thrushMedDRA releases: 2024-11 · check-in free text available
-
2022-12-12
Survey response — 12 months, dose 3MedDRA: Pityriasis rosea — Feeling: GoodFree text: rash (pityriasis rosea)MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-17 | Pfizer-BioNTech | |
| 3 | 2021-12-12 | Moderna | No |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Lymph node under the injection site arm is painful and swollen
Systemic reaction (other): swollen and sore lymph node in armpit of injected arm
Release 9 — 3 months, dose 2
Symptoms: I have a cold
Release 11 — 12 months, dose 2
Symptoms: I don't normally get migraines but my COVID booster triggered about a week and a half of severe migraines with sensitivity to light in addition to the typical symptoms. I've had the occasional migraine since then
Release 12 — 6 months, dose 3
Symptoms: I tested positive for COVID on May 31, 2022 and had fever and moderate respiratory symptoms. It also caused white dots on my tongue which I think is oral thrush
Release 12 — 12 months, dose 3
Symptoms: rash (pityriasis rosea)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oral candidiasis | · | · | ✓ |
| SD | Photophobia | · | · | ✓ |
| SD | Pityriasis rosea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Tongue discolouration | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release